Companhia Siderurgica Nacional ADR (SID) Stock Price, Quote & News

Company Profile

Companhia Siderúrgica Nacional, together with its subsidiaries, operates as an integrated steel producer in Brazil and internationally. It operates through five segments: Steel Industry, Mining, Logistics, Energy, and Cement. The Steel Segment offers produce and sells of flat and long steel. The Mining Segment engages in extraction, processing and marketing of iron ore, tin, limestone, and dolomite. The Logistics Segment supplies railways, port concessions, and road fleet. The Cement Segment pro...

Industry: Steel

Sector: Basic Materials

Phone: 55 11 3049 7100

Website: www.csn.com.br

Address:

Av. Brigadeiro Faria Lima, 3400, 0th Floors Itaim Bibi, São Paulo, Brazil

VirusRaven Jun. 9 at 5:42 PM

$SID https://www.reuters.com/legal/transactional/brazils-csn-receive-binding-offers-cement-unit-until-august-7-valor-reports-2026-06-03/ Might be the reason for the drop... the market expected for this to happen this month

0 · Reply

dhlskurp Jun. 2 at 6:27 PM

$SID on my face

0 · Reply

MarketBeat May. 15 at 9:11 AM

https://marketbeat.com/a/8655986/ $SID National Steel Q1 Earnings Call Highlights

0 · Reply

BN99 May. 14 at 8:45 PM

$SID CSN announced that it has received at least seven bids for its cement division, which was put up for sale as part of the company's strategy to reduce its debt. CFO Antonio Marco Rabello stated that the interest from "extremely qualified" groups shows that the process is progressing on the expected schedule. According to him, the cement unit recorded the highest quarterly EBITDA in its history, even during a traditionally weaker period for the sector. https://valor.globo.com/empresas/noticia/2026/05/14/csn-diz-que-recebeu-sete-propostas-para-divisao-de-cimento.ghtml

1 · Reply

EarningsInsider May. 14 at 6:31 PM

https://www.marketbeat.com/earnings/reports/2026-5-14-companhia-siderrgica-nacional-stock/ $SID National Steel Earnings Transcript

0 · Reply

BN99 May. 12 at 7:42 PM

$SID https://www.reuters.com/legal/transactional/brazils-csn-receives-offers-its-cement-unit-sources-say-2026-05-12/

0 · Reply

shnitzerbittle May. 5 at 3:38 PM

$SID They have at least 14 bidders on the cement. If they can get 3-4 billion for it and pay off an equal amount of debt each ADR share should be worth between 2.1 and 4.40 per share based on 10pe and expected income, provided the rest of the business stays stable.

1 · Reply

SuperGreenToday Apr. 29 at 10:19 AM

$SID Share Price: $1.29 Contract Selected: Dec 18, 2026 $0.5 Calls Buy Zone: $0.69 – $0.85 Target Zone: $1.11 – $1.35 Potential Upside: 52% ROI Time to Expiration: 232 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Betao Apr. 27 at 12:37 PM

$SID youtu.be/9Dvt07_tdBY very good analyse for $SID i increased my position last friday and will add one more hand still

0 · Reply

BN99 Apr. 21 at 4:06 PM

$SID 🧐👀 Sources close to potential bidders estimate the asset could be valued between R$10 billion and R$15 billion, while CSN is reportedly seeking around R$20 billion for the business. The transaction is expected to involve the sale of 100% of the unit. https://valorinternational.globo.com/business/news/2026/04/14/csn-cimentos-sale-draws-strong-interest.ghtml

0 · Reply

National Steel Q1 Earnings Call Highlights

2026-05-15T09:11:47.000Z - 25 days ago

National Steel Q1 Earnings Call Highlights

May 14, 2026, 10:30 AM EDT - 26 days ago

Companhia Siderúrgica Nacional Earnings Call Transcript: Q1 2026

May 14, 2026, 10:30 AM EDT - 26 days ago

Companhia Siderúrgica Nacional Earnings release: Q1 2026

May 14, 2026, 10:30 AM EDT - 26 days ago

Companhia Siderúrgica Nacional Slides: Q1 2026

Thu, 14 May 2026 07:00:00 -0400 - 26 days ago

Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting

Thu, 07 May 2026 09:00:00 -0400 - 4 weeks ago

TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis

Tue, 05 May 2026 16:05:00 -0400 - 5 weeks ago

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting

2026-05-05T17:51:56.000Z - 5 weeks ago

See How Companhia Siderurgica Nacional Ranks Among Analysts' Top Metals Picks

Thu, 30 Apr 2026 18:01:00 -0400 - 5 weeks ago